APSR2026-463

Yes
Late-Breaking
Submitted
Oral Presentation
AO19-006
 
 
https://storage.unitedwebnetwork.com/files/1285/1210845-46903-APSR2026-463_439808.pptx
Format: PPTX Only
 
Format: PDF Only
08. Lung Cancer
9

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Rizki Putra Sanjaya * Faculty of Medicine Lampung University Department of Pulmonology and Respiratory Medicine Bandar Lampung Indonesia Dr. Bob Bazar Hospital Department of Pulmonology and Respiratory Medicine South Lampung Indonesia
Tito Tri Saputra - Faculty of Medicine Lampung University Department of Pulmonology and Respiratory Medicine Bandar Lampung Indonesia Dr. H. Abdul Moeloek Hospital Lampung Province Department of Pulmonology and Respiratory Medicine Bandar Lampung Indonesia Alimuddin Umar Hospital Department of Pulmonology and Respiratory Medicine West Lampung Indonesia
Andreas Infianto - Faculty of Medicine Lampung University Department of Pulmonology and Respiratory Medicine Bandar Lampung Indonesia Ahmad Yani General Hospital Department of Pulmonology and Respiratory Medicine Metro Indonesia
Sukarti Sukarti - Faculty of Medicine Lampung University Department of Pulmonology and Respiratory Medicine Bandar Lampung Indonesia Dr. H. Abdul Moeloek Hospital Lampung Province Department of Pulmonology and Respiratory Medicine Bandar Lampung Indonesia
Retno Ariza Soeprihatini Soemarwoto - Faculty of Medicine Lampung University Department of Pulmonology and Respiratory Medicine Bandar Lampung Indonesia
Adityo Wibowo - Faculty of Medicine Lampung University Department of Pulmonology and Respiratory Medicine Bandar Lampung Indonesia
Tetra Arya Saputra - Faculty of Medicine Lampung University Department of Pulmonology and Respiratory Medicine Bandar Lampung Indonesia Dr. H. Abdul Moeloek Hospital Lampung Province Department of Pulmonology and Respiratory Medicine Bandar Lampung Indonesia
Dwi Robbiardy Eksa - Metro Islamic Hospital Department of Pulmonology and Respiratory Medicine Metro Indonesia Faculty of Medicine Malahayati University Department of Pulmonology and Respiratory Medicine Bandar Lampung Indonesia
Adhi Nugroho Latief - Bhayangkara Polda Banten Hospital Department of Pulmonology and Respiratory Medicine Serang Indonesia
 
 
 
 
 
 
Presenting Author Details
Rizki Putra
Sanjaya
rizkipsanjaya@gmail.com
+628117251115
31-40
Indonesia
Original Research
Development of The UNILA Score: A Simple Prediction Model for Progressive Disease in Lung Adenocarcinoma
Maximum 25 words
Abstract Content
Identifying patients at risk of progressive disease (PD) after chemotherapy in lung adenocarcinoma remains challenging. This study aimed to develop the University of Lampung Nutrition–Inflammation Lung Adenocarcinoma (UNILA) Score combining albumin, neutrophil percentage, and transforming growth factor beta (TGF-β) to predict disease progression.
This was an analytical study of 35 lung adenocarcinoma patients receiving first-line chemotherapy. Response evaluated using Response Evaluation Criteria in Solid Tumors (RECIST). The UNILA Score included albumin <3.2 g/dL, neutrophil ≥78.5%, and TGF-β ≥62,500 pg/mL (score 0–3). Associations analyzed using Chi-square, logistic regression, and ROC analysis.
Stable disease occurred in 51.4%, progressive disease in 48.6%. Hypoalbuminemia was present in 62.9%, elevated TGF-β in 60%, and high neutrophil percentage in 100%. UNILA Score showed significant association with PD (p<0.05). ROC analysis demonstrated score ≥2 as optimal cut-off.
The UNILA Score is a simple and clinically applicable biomarker-based scoring system to identify patients at higher risk of progressive disease after chemotherapy.
 
 
 
 
 
Yes
Yes
https://storage.unitedwebnetwork.com/files/1285/1210845-37089-Tabel_380421.png
JPG or JPEG or PNG format ONLY
Lung adenocarcinoma; Inflammation biomarkers; Disease progression
maximum 3 keywords and no abbreviations, separated by commas
CONFLICT OF INTEREST STATEMENT: None declared. DATA AVAILABILITY STATEMENT: The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. ETHICS STATEMENT: The authors declare that appropriate written informed consent was obtained for the publication of this manuscript and accompanying images.
165